{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:40:03Z","timestamp":1777581603584,"version":"3.51.4"},"reference-count":6,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>to study in patients with Beh\u00e7et disease and ocular involvement (OBD) the presence of SARS-CoV-2 infection and its influence on the course of OBD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>all the patients with OBD living in Lazio, one Italian region, and attending the Uveitis center of the Sapienza University of Rome were included in the study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>SARS-CoV-2 infection was found in 12.3% of 54 patients with OBD and in 3.84% of Lazio inhabitants (p\u2009\u2009=\u2009\u20090.001, OR 3.51), and it was unrelated to the use of immunosuppressive drugs. COVID-19 symptoms in OBD patients were mild, with one patient only requiring hospitalization for interstitial pneumonia. None of the SARS-CoV-2 infected patients presented any uveitis relapses during the infection and in a subsequent median follow-up of 6 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>OBD seems to be a risk factor for developing SARS-CoV-2 infection. Usually this infection has a mild course and does not impact negatively on the course of uveitis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11206721221074437","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T12:34:41Z","timestamp":1642768481000},"page":"NP148-NP149","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Ocular Beh\u00e7et disease and COVID-19"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-1455","authenticated-orcid":false,"given":"Massimo","family":"Accorinti","sequence":"first","affiliation":[{"name":"Ocular Immunovirology Service \u2013 Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priscilla","family":"Manni","sequence":"additional","affiliation":[{"name":"Ocular Immunovirology Service \u2013 Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Sampalmieri","sequence":"additional","affiliation":[{"name":"Ocular Immunovirology Service \u2013 Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Carmela","family":"Saturno","sequence":"additional","affiliation":[{"name":"Ocular Immunovirology Service \u2013 Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"bibr1-11206721221074437","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217424"},{"key":"bibr2-11206721221074437","doi-asserted-by":"crossref","first-page":"676","DOI":"10.55563\/clinexprheumatol\/lekp1y","volume":"39","author":"Brito-Zeron P","year":"2021","journal-title":"Clin Exp Rheumatol"},{"key":"bibr3-11206721221074437","first-page":"808","volume":"2018","author":"Hatemi G","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"bibr4-11206721221074437","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2020.06.213"},{"key":"bibr5-11206721221074437","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217778"},{"key":"bibr6-11206721221074437","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-020-02427-8"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721221074437","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11206721221074437","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11206721221074437","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:46:01Z","timestamp":1777405561000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11206721221074437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["10.1177\/11206721221074437"],"URL":"https:\/\/doi.org\/10.1177\/11206721221074437","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]}}}